Immune-deficient animals to study “hormone-dependent” breast and endometrial cancer

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

B. Fisher, Carol Redmond, R Poisson et al. · New England Journal of Medicine · 1989 · 1.5K citations

Medicine, Oncology, Pharmacotherapy +13

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.

Yolande Berthois, John A. Katzenellenbogen, Benita S. Katzenellenbogen · Proceedings of the National Academy of Sciences · 1986 · 1.3K citations · Full text

Life Sciences, Biochemistry, Endocrinology +13

Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

Cornelius Knabbe, Marc E. Lippman, Lalage M. Wakefield et al. · Cell · 1987 · 982 citations

Life Sciences, Cell Biology, Oncology +12

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

New England Journal of Medicine · 1988 · 938 citations

Medicine, Oncology, Breast Oncology +13

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

Tommy� Fornander, Björn Cedermark, Anders Mattsson et al. · The Lancet · 1989 · 930 citations

Medicine, Oncology, Pharmacology +12